noom glp-1 cost without insurance Ozempic and Wegovy are marketed as a short-term holy grail for weight loss by some startups. Doctors disagree Noom Introduces Industry-First $129 Compounded

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management

Lancet 382:339352 Thomas MC, Cooper ME, Zimmet P (2016) Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

That said, not everyone responds the same way to GLP-1s

The company submitted a public comment in November and launched its own GLP-1 Supply Tracker to gather evidence of shortages, reporting that nearly 80,000 customers have indicated difficulties accessing these medications through pharmacies

9 Thomas, M.K., et al., Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

Customized physician-backed treatment plan Every patient is seen by a board-certified primary care physician experienced in caring for patients with weight concerns